Catalogo dei prodotti della ricerca

DE SANTIS, Adriano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.551
EU - Europa 5.222
AS - Asia 1.034
AF - Africa 67
SA - Sud America 47
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.456
IT - Italia 3.882
SG - Singapore 423
IN - India 333
SE - Svezia 315
UA - Ucraina 207
FI - Finlandia 205
CN - Cina 199
DE - Germania 167
GB - Regno Unito 95
FR - Francia 77
CA - Canada 72
NL - Olanda 48
IE - Irlanda 46
BG - Bulgaria 42
AR - Argentina 36
BE - Belgio 27
CH - Svizzera 21
TG - Togo 21
AT - Austria 20
ID - Indonesia 20
BJ - Benin 18
RO - Romania 15
RU - Federazione Russa 14
ZA - Sudafrica 12
MX - Messico 11
MY - Malesia 9
TR - Turchia 9
IR - Iran 8
PK - Pakistan 8
BZ - Belize 7
PL - Polonia 7
PT - Portogallo 7
EG - Egitto 6
AL - Albania 5
BR - Brasile 5
HK - Hong Kong 5
CO - Colombia 4
ES - Italia 4
KR - Corea 4
SC - Seychelles 4
VN - Vietnam 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
DZ - Algeria 2
HR - Croazia 2
JP - Giappone 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SA - Arabia Saudita 2
SI - Slovenia 2
TW - Taiwan 2
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
JO - Giordania 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.927
Salva come PNG Salva come JPEG
Città #
Fairfield 1.079
Rome 638
Woodbridge 562
Chandler 496
Ashburn 446
Seattle 383
Houston 367
Wilmington 356
Cambridge 328
Singapore 292
Ann Arbor 258
Milan 230
Princeton 209
Plano 154
Dearborn 146
Santa Clara 126
San Paolo di Civitate 115
Florence 96
Lawrence 93
Naples 92
Millbury 91
Beijing 87
Palermo 87
Jacksonville 83
Turin 72
Boston 68
San Diego 67
Helsinki 64
Andover 59
Bologna 50
Catania 50
Des Moines 49
Fremont 47
Ottawa 47
Bari 45
Dublin 45
Bremen 36
Federal 36
Sofia 35
New York 33
Norwalk 31
Pisa 31
Falls Church 29
Brussels 27
Genoa 27
Lucca 27
Livorno 26
Boardman 25
Frankfurt am Main 25
Perugia 25
San Jose 25
Brescia 24
Falkenstein 22
Lomé 21
Southend 21
Verona 20
Jakarta 19
Reggio Emilia 19
Vienna 19
San Mateo 18
Toronto 18
Cagliari 17
Dallas 17
Fasano 17
Padova 17
Bühl 15
Camden 14
Caserta 14
London 12
Los Angeles 12
Monza 12
Auburn Hills 11
Formigine 11
Johannesburg 11
Kunming 11
Nanjing 11
Pescara 11
Salerno 11
Bergamo 10
Rimini 10
Arezzo 9
Hefei 9
Mannheim 9
Parma 9
Ravenna 9
Altopascio 8
Cascina 8
Empoli 8
Iesi 8
Lamezia Terme 8
Latina 8
Belize City 7
Cosenza 7
Grezzana 7
Kuala Lumpur 7
Legnano 7
Mascalucia 7
Modena 7
Moscow 7
Mumbai 7
Totale 8.516
Salva come PNG Salva come JPEG
Nome #
Ridotta prevalenza di “skip areas” nel fegato steatosico in pazienti con calcolosi multipla della colecisti ed in soggetti colecistectomizzati 2.519
FISIOLOGIA DEL FEGATO E METABOLISMO ENERGETICO 984
Angiogenic factors as prognostic markers in neuroendocrine neoplasms 171
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 121
Diagnostic imaging for hepatocellular carcinoma 108
Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: A pilot study 106
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hcv-related cirrhosis 104
Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors 103
Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? 100
Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control 99
An isolate alpha-fetoprotein producing gastric cancer liver metastasis emerged in a patient previously affected by radiation induced liver disease 98
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 97
Intestinal Permeability In Non-Alcoholic Fatty Liver Disease: The Gut-Liver Axis. 93
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. 91
The human gut microbiota and virome: potential therapeutic implications 91
Application of acoustic radiation force impulse elastography in non invasive diagnosis of focal nodular hyperplasia 90
The activation of IGF1 system is a requisite for cholangiocyte survival during the progression of primary biliary cirrhosis (PBC) 89
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement 89
Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis 88
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy. 86
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 86
Nutritional habits in patients with chronic liver disease: adherence of real life diet to international guidelines and its association with disease stage 85
HAMP GENE MUTATION C.208T>C (P.C70R) IDENTIFIED IN AN ITALIAN PATIENT WITH SEVERE HEREDITARY HEMOCHROMATOSIS. 84
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 84
One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation 83
Reduced lysosomal acid lipase activity in blood and platelets is associated with nonalcoholic fatty liver disease 83
ACOUSTIC RADIATION FORCE IMPULSE ELASTOGRAPHY" (ARFI) ASSESSMENT OF FOCAL NODULAR HYPERPLASIA: PRELIMINARY RESULTS 81
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 81
Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C 80
Clinical course, management, and platelet activity assessment of splanchnic VITT: a case report 79
Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis 78
The modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt 78
PREDICTIVE RISK FACTORS OF RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION 78
Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients 78
Management of refractory typical GERD symptoms 78
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis 77
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection 77
Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results 77
ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION 76
Clinical Manifestations of gallstone disease: evidence from the Multicenter Italian study on Cholelithiasis (MICOL) 75
Probiotics for the hemodynamic alterations of patients with liver cirrhosis. 74
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis. 74
Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging 74
Bile acid metabolism in liver disease 73
Ultrasonography in the study of hepatocellular carcinoma in woodchucks chronically infected with WHV 73
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 73
Hepatic steatosis after liver transplantation: Prevalence and associated factors 72
ARFI Elastometry Assessment of Focal Nodular Hyperplasia: Preliminary Results 72
Expression of estrogen receptors in cholangiocytes of patients with primary biliary cirrhosis (PBC) and relationship with immunohistochemical markers of cell proliferation and death 70
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis. A real-life study 70
Epidemiologia della colelitiasi in Italia . Esperienze del GREPCO: Gruppo Romano per l'Epidemiologia e la Prevenzione della Colelitiasi 69
Epidemiology of gallstone disease in Italy: Prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) 69
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. 69
Transjugular intrahepatic portosystemic shunt (TIPS) is feasible in non-cirrhotic patients with cavernomatous tranformation of the portal vein 68
Kinetic characterisation in needle biopsies of hepatocellular carcinama: feasibility and preliminari results. 66
Biliary Secretion of Phosphatidylcholine and its molecular species in cholecystectomized T - Tube patients: Effects of bile acid hydrophilicity. 66
Prevalenced of portal vein thrombosis (PVT) and associated factors in cirrhotic patients 66
Gallstones and diabetes: a case - control study in a free - living population sample. 65
IS SKIN TOXICITY A PREDICTOR OF BETTER SURVIVAL OF PATIENTS WITH HCC TREATED WITH SORAFENIB? 65
PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis 65
Diet and gallstones in Italy: The cross-sectional MICOL results 65
Prevalence of gallstone disease in an Italian adult female population. 63
Increased resting energy expenditure in patients with hepato cellular carcinoma 63
Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma. 63
Beta adrenergic receptors in the parathyroid glands. 63
Biliary sludge: a critical update. 62
A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B. 62
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. 62
Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody 62
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients 62
Incidence and natural history of small esophageal varices in cirrhotic patients 61
Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: A retrospective case-control study 61
Clinical symptoms and gallstone disease: lessons from a population study 61
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts 61
Is skin toxicity a predictor of better survival of patients with HCC treated with sorafenib? 60
The natural history of gallstones: the GREPCO experience 60
Severe rectal prolapse and solitary rectal ulcer in a young anorectic woman with myxoid degeneration of visceral adipose tissue 60
PRESENTATION OF THE RIFLE PROJECT RISK-FACTORS AND LIFE EXPECTANCY 59
Sterile abscesses complicating monoclonal gammopathy of undetermined significance. 59
Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis 58
Correction to: Reduced lysosomal acid lipase activity in blood and platelets Is associated with nonalcoholic fatty liver disease 58
TREATMENT WITH INTERFERON (IFN) PLUS RIBAVIRIN (RBV) OF β-THALASSEMIC PATIENTS WITH HCV CHRONIC HEPATITIS 57
Prevalence of gallstone disease in first-degree relatives of patients with cholelithiasis. 57
Cost analysis for the prevention of variceal rebleeding in cirrhotic patients: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy 56
Effect of a medium dose of Ursodeoxycholic acid with or without Taurine supplementation on the nutritional status of patients with Cystic fibrosis:A randomized, placebo-controlled,crossover trial 55
Cholelithiasis and blood groups: evidence for a lack of association 55
Gallbladder ultrasonography as a diagnostic tool in epidemiological screenings 55
IS SKIN TOXICITY A PREDICTOR OF BETTER SURVIVAL OF PATIENTS WITH HCC TREATED WITH SORAFENIB? 55
null 54
Etiology, management, and outcome of the Budd-Chiari syndrome. 54
Clinico-immunologic outcomes of HCV-cured cryoglobulinemia: lower relapse rate with interferon-based than interferon-free therapy 54
The GREPCO research programmes: aims and prevalence data. 53
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study 53
Role of Octreoscan in advanced hepatocellular carcinoma 52
Dermatologic lesions in patients with chronic hepatitis C treated with alfs interferon alone or in combination with ribavirin and with or without amantadine 52
Small hepatic veins Budd-Chiari syndrome and paroxysmal nocturnal hemoglobinuria - The association of two rare entities: a case report 52
Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis 52
Portal vein thrombosis (PVT) in cirrhotic patients: Prevalence and associated factors 51
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma 51
null 51
Totale 10.622
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.311
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.507 0 0 0 0 0 408 297 261 235 151 87 68
2020/2021947 101 95 54 112 42 63 19 79 77 199 71 35
2021/20221.967 37 79 167 56 259 72 65 213 166 158 312 383
2022/20232.706 408 376 117 295 269 259 142 179 245 123 165 128
2023/20242.272 134 188 170 198 206 239 224 206 51 238 189 229
2024/20251.434 218 217 263 219 311 206 0 0 0 0 0 0
Totale 13.218